zulooani.blogg.se

Hx of atrial flutter icd 10
Hx of atrial flutter icd 10











hx of atrial flutter icd 10

  • Other uses of radiofrequency catheter ablation not indicated above (e.g., AV junction ablation in combination with pacemaker implantation for symptomatic drug-refractory atrial fibrillation) or.
  • Multifocal atrial tachycardia (MAT) or.
  • Benign non-sustained VT that does not cause symptoms or.
  • The procedure is performed through an incision to ablate (destroy) the arrhythmic area of the heart.Īetna considers cardiac catheter ablation procedures experimental and investigational for all other indications, including any of the following arrhythmias, as there is insufficient evidence in the peer-reviewed medical literature of the effectiveness of cardiac catheter ablation for these indications: This procedure may be used to eliminate AV condition defects.
  • Non-sustained VT that is symptomatic when the tachycardia is drug-resistant or the member is drug-intolerant or does not desire long-term drug therapy.Īetna considers operative ablation medically necessary.
  • Members with symptomatic sustained monomorphic VT when the tachycardia is drug-resistant or the member is drug-intolerant or does not desire long-term drug therapy or.
  • Members with sustained monomorphic VT and an implantable cardioverter-defibrillator (ICD) who are receiving multiple shocks not manageable by re-programming or concomitant drug therapy or.
  • Members with bundle branch reentrant ventricular tachycardia or.
  • Members with symptomatic AV reentrant tachycardia that is drug-resistant or the member is drug-intolerant or does not desire long-term drug therapy.
  • Members with AV reentrant tachycardia or atrial fibrillation with rapid ventricular rates identified during electrophysiological study of another arrhythmia or.
  • Members with atrial fibrillation and a controlled ventricular response via the accessory pathway or.
  • Members with atrial fibrillation (or other atrial tachyarrhythmias) and a rapid ventricular response via the accessory pathway when the tachycardia is drug-resistant or the member is drug-intolerant or does not desire long-term drug therapy or.
  • Members with a family history of sudden cardiac death or.
  • Asymptomatic members with ventricular pre-excitation whose livelihood or profession, important activities, insurability, or mental well being or the public safety would be affected by spontaneous tachyarrhythmias or the presence of the electrocardiographic abnormality or.
  • Accessory pathways (including Wolfe-Parkinson-White ).
  • Members with atrial tachycardia that is drug-resistant or the member is drug-intolerant or does not desire long-term drug therapy.
  • Members with atrial flutter/atrial tachycardia associated with paroxysmal atrial fibrillation when the tachycardia is drug-resistant or the member is drug-intolerant or does not desire long-term drug therapy or.
  • Members with atrial flutter that is drug-resistant or the member is drug-intolerant or does not desire long-term drug therapy or.
  • Members with atrial fibrillation and evidence of a localized site(s) of origin when the tachycardia is drug-resistant or the member is drug- intolerant or does not desire long-term drug therapy (e.g., pulmonary vein isolation procedures) or.
  • Atrial tachycardia, flutter, and fibrillation.
  • The finding of dual atrio-ventricular (AV) nodal pathway physiology and atrial echoes but without AVNRT during electrophysiological study in members suspected of having AVNRT clinically.
  • Members with symptomatic sustained AVNRT that is drug-resistant or the member is drug-intolerant or does not desire long-term drug therapy or.
  • Members with sustained AVNRT identified during electrophysiological study or catheter ablation of another arrhythmia or.
  • Atrioventricular nodal reentrant tachycardia (AVNRT).
  • Members with symptomatic non-paroxysmal junctional tachycardia that is drug-resistant, drugs are not tolerated, or the member does not wish to take them.
  • Members with symptomatic atrial tachyarrhythmias who have inadequately controlled ventricular rates or.
  • Members with symptomatic atrial tachyarrhythmias such as those above but when drugs are not tolerated or the member does not wish to take them, even though the ventricular rate can be controlled or.
  • Members with a dual-chamber pacemaker and pacemaker-mediated tachycardia that cannot be treated effectively by drugs or by re-programming the pacemaker or.
  • Members resuscitated from sudden cardiac death due to atrial flutter or atrial fibrillation with a rapid ventricular response in the absence of an accessory pathway or.
  • In members who meet any of the following: Aetna considers cardiac catheter ablation procedures medically necessary for any of the following arrhythmias:













    Hx of atrial flutter icd 10